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Background
The acquisition of somatic alterations (point mutations/
chromosomal rearrangements) underlies the hallmarks of
cancer, generating genetic diversity that drives tumorigen-
esis. Advances in the study of cancer genomes revealed in
solid tumors a complex pattern of copy number altera-
tions (CNA), structural rearrangements, and aneuplodies.
Breast cancer (BC) is the most common malignancy in
females, being the leading cause of death by cancer. This
heterogeneous disease is not fully understood yet; how-
ever, genomic studies have identified unique CNA pat-
terns in different BC subtypes. Regarding the subtype
triple-negative (TN; estrogen and progesterone receptors,
and HER2 negative expression levels), only limited data
are available on which genes or chromosome regions are
involved in its initiation and progression.
Material and methods
We assessed the genomic profile of CNAs in 16 triple-
negative breast carcinomas (TNBC), aiming to identify
genomic markers related to lymph node status that could
be of clinical importance. The array-CGH survey were
conducted on primary TNBC samples, obtained from
patients with (8) and without (8) lymph node metastasis
at diagnosis. Data was obtained using a 60K oligoarray
(OGT), with average probe spacing ~50kb, and analysis
was performed on the software Nexus Copy Number 6.0
(Biodiscovery).
Results and discussion
The most prevalent chromosomal alterations were losses
at 3p, 4q, 5q, 8p, 13q, 18, and 21q; additionally, gains on
1q, 3q, 8q, 10p, 17q e 19 were frequent events. However,
although these CNAs have been detected in >50% of all
samples, most of them exhibited low log2 ratios values,
indicating that they were present in mosaic. Notably,
TNBC from patients with lymph node metastasis exhibited
a slightly distinctive pattern of genomic alterations, mainly
characterized for a significantly increased frequency of low
amplitude losses at 13q and 18q, and gain at 19p. The
most relevant CNA associated with TNBC positive for
lymph node metastasis was the gain of a small segment at
19p13.11 (660kb), harboring at least 20 RefSeq genes (gain
detected in 5/8 TNBC positive and 0/8 negative for lymph
node metastasis).
Conclusion
The recurrence of specific CNAs in cancer indicates sites
likely harboring genes whose copy number changes favors
neoplastic progression. Therefore, recognizing specific pat-
terns of genomic alterations associated to lymph node
metastasis in primary TNBC can provide clues on the
mechanisms driving its progression. In a progressive
model of tumor evolution we can propose a link between
the somatic acquisition of the 19p13.11 gain in TNBC and
the occurrence of lymph node metastasis. It is interesting
to mention that a recent study (Stevens et al, Cancer Res
2012) discloses a 19p13.11 SNP variant associated with
risk of TNBC; our finding reinforces the role of this geno-
mic region for this BC subtype.* Correspondence: felipe.fidalgo9@gmail.com1CIPE, AC Camargo Hospital, São Paulo, Brazil
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